Finanzen von Windtree Therapeutics Inc (WINT)WINTWindtree Therapeutics Inc

Evaluating the bottom line, Windtree Therapeutics Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -1225.98%, provide a clear picture of how effectively WINT converts its operational activities into shareholder value.

In the context of the broader market, WINT competes directly with industry leaders such as ALLR and CLRB. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, WINT's gross margin of N/A stands against ALLR's 100.00% and CLRB's N/A. Such benchmarking helps identify whether Windtree Therapeutics Inc is trading at a premium or discount relative to its financial performance.